Showing results (1-10 of 162) with videos related to
Sort By:
Pageof 17
Clinical Immunology (Orlando, Fla.)|March 4, 2021
The efficacy of PD-1/PD-L1 blockade in cold cancers and future perspectivesJamal Majidpoor, Keywan MortezaeeCellular Oncology (Dordrecht, Netherlands)|April 9, 2021
Angiogenesis as a hallmark of solid tumors - clinical perspectivesJamal Majidpoor, Keywan MortezaeeInternational Reviews of Immunology|July 6, 2022
Dysregulated metabolism: A friend-to-foe skewer of macrophagesKeywan Mortezaee, Jamal MajidpoorBiomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|November 15, 2021
Interleukin-6 in SARS-CoV-2 induced disease: Interactions and therapeutic applicationsJamal Majidpoor, Keywan MortezaeeFrontiers in Immunology|April 18, 2022
CD8+ T Cells in SARS-CoV-2 Induced Disease and Cancer-Clinical PerspectivesKeywan Mortezaee, Jamal MajidpoorCancer Medicine|March 18, 2022
Checkpoint inhibitor/interleukin-based combination therapy of cancerKeywan Mortezaee, Jamal MajidpoorJournal of Cellular and Molecular Medicine|January 10, 2023
Transforming growth factor-β signalling in tumour resistance to the anti-PD-(L)1 therapy: UpdatedKeywan Mortezaee, Jamal MajidpoorMedical Oncology (Northwood, London, England)|June 18, 2022
NK and cells with NK-like activities in cancer immunotherapy-clinical perspectivesKeywan Mortezaee, Jamal MajidpoorMedical Oncology (Northwood, London, England)|March 25, 2023
The impact of hypoxia on extracellular vesicle secretome profile of cancerKeywan Mortezaee, Jamal MajidpoorFrontiers in Immunology|December 12, 2022
Cellular immune states in SARS-CoV-2-induced diseaseKeywan Mortezaee, Jamal MajidpoorPageof 17